SOHM Inc (SHMN)

[hardlesson]

https://x.com/sohminc/status/1775516437441896865?s=20

[Myth]

Total Assets.

3rd qtr - 860,617
4th qtr - 1,500,629

Equipment rose from 204,637 to 769,748

prevously 44,120 in the 2'd qtr,

4th qtr G&A 363,948 up from 113,973

As we all know it takes money to make money, what I see here is a great start to building this co. And ABBIE is going to be the icing on the cake, stay tuned !

[MDPennyPlayer]

There was major growth in the financials, just on the liabilities and expenses side. Glad they finally started to account for it. Now they will need exponential growth to keep up with the money going out going forward. I wouldn't hold my breath for that though.

[Myth]

now that's a good way to start out the week !

[hardlesson]

Eddie Chung, Coastar CEO: "This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."

[hardlesson]

https://coastartherapeutics.com/about-us/

[hardlesson]

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

https://www.globenewswire.com/news-release/2024/04/01/2855240/0/en/SOHM-Inc-and-Coastar-Therapeutics-Sign-MoU-and-Announce-Collaboration-to-Revolutionize-Genome-Editing-Using-Red-Blood-Cell-Membrane-Derived-Carriers.html

[Myth]

Anyone who expected a great 4th qtr here hasn't been paying attention.....

[MPstock]

Typical

[drugmanrx]

Growth but minuscule.

Hoping by the end of 2024 SOHM is during quarters greater then it's 2023 annual revenue.

[hardlesson]

2023 Annual Report filed:

https://www.otcmarkets.com/stock/SHMN/disclosure

__
hL

[Fallingknife75]

The only reliable short volume data is posted by FINRA on a bi-weekly basis. The data for daily short volume sites such as you posted is derived from FINRA's volume numbers, but due to how it is calculated it is misleading at best. Once you understand this you will never use daily short report numbers again. The link provided is an article written several years ago by R. Cromwell Coulson, President, CEO and a Director of OTC Markets Group.

https://blog.otcmarkets.com/2018/11/13/understanding-short-sale-activity/

For SHMN, the latest numbers from FINRA were posted on 03/15/2024 with 8,249 shares short.

All the best,

Knife

[QUEEN2]

Historical Short Volume Data for SHMN :
Mar 28
Vol 5,878,050
Short Vol 4,993,684
84.95%
Mar 27 : 91,13%
Mar 26 : 95,90%
https://www.otcshortreport.com/company/SHMN

[Myth]

I wonder if any of the Japanese co's that are in negotiations with SHMN will be present at AACR ?

Have a great weekend all, more fun next week !

[Myth]

thx hl....

[Fallingknife75]

Lol, nonsense. Shorts are just an easy foil to blame when people are looking for excuses. They exist, but are not nearly as prevelant as "everyone" thinks.

Knife

[hardlesson]

I'm pretty sure this is our Mark Stevens:

"Scientist, Pharmacology & Toxicology, Biochemistry; Intellectual Property "

"Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer."

Another University of Arizona guy.
https://www.linkedin.com/in/mark-stevens-phd-810167a/

Impressive Resume, imo. Now also works for US Dept. of Commerce.

Skills include Cancer Research:
https://www.linkedin.com/in/mark-stevens-phd-810167a/details/skills/
https://www.linkedin.com/in/mark-stevens-phd-810167a/details/publications/

https://x.com/hardlesson1/status/1773404706577977562?s=20


__
hL imo. shmn

[6of1]

sorry to let the cat out of the bag but everyone knows the otc is at least 60% shorters

[Myth]

do you think OTC Markets should be alerted to this misspelling ?

make sure you list every time this has happened...lol....

Typical SHMN

[Fallingknife75]

Thanks for the update, looks like we have some Bidders showing up.

All the best,

Knife

[MDPennyPlayer]

They can't even spell Aguilar's name correctly in their graphic..... Typical SHMN

[hardlesson]

https://x.com/sohminc/status/1773395245264245123?s=20

"Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer."


Mark Stevens.

__
hL shmn

[Myth]

really, you can't wait ??

sitting on pins and needles ?

that's sad...

[MDPennyPlayer]

Can't wait to see the yearly financial report that's due shortly. Should have how much of that "up to 5 million" funding SHMN has gotten. Also manufacturing equipment, two facility costs, etc...

[Fallingknife75]

Yet here you are, interesting.

[Myth]

exactly, and will bring legitimency to ABBIE and SHMN.

SHMN kas the potential to fly from this level and leave the flippy dippy OTC traders behind.

WAY behind...

GL Knife

[Myth]

lol....so short it then....

[6of1]

this stock is bait for the unsophisticated and easyly fooled

[Fallingknife75]

Agreed, licensing deals are basically all profit, having no "cost of goods sold", and would be a huge catalyst for the company as well as the stock.

All the best,

Knife

[Myth]

all this needs now is a licensing deal announced...

SOHM, Inc.
@sohminc
The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to maximizing benefits for the company and its stakeholders.”

[NorthShoreTrading]

This should move much higher into April 8th unveiling!!

[Myth]

Funny how Auguilar's worth changes from day to day....lol....so what is it ?

Aguilar is what they needed to get the stink of Baron off of this. Seems to have the connections to get this going. Hopefully we see more updates.

[Myth]

keep hoping....

[Myth]

SOHM, Inc.
@sohminc
The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to maximizing benefits for the company and its stakeholders.”

If you need further refinement or have any additional requests, feel free to ask!

$SHMN
#GeneEditing
#pharmaceutical

[MDPennyPlayer]

No one cared about ABBIE 8 yrs ago. Just like they don't care about it now.

[Myth]

no one cares about 8 years ago....

[MDPennyPlayer]

Maybe Aguilar can reuse his pitch from 8 yrs ago....

[Myth]

the paid basher is always lurking....kinda creepy imo..

[Myth]

lol...seriously, you aren't going to retract that lie ?

They don't have an exhibit or are they speaking about ABBIE during the conference.

[Myth]

https://money.tmx.com/quote/SHMN:US/news/6895075540545659/SOHM_Collaborates_with_University_of_Arizona_Center_for_Innovation_to_Advance_ABBIE_a_Groundbreaking_NonViral_GeneEditing_Technology

[Myth]

so don't buy the stock and move on to what you think is a greener pasture....

[MDPennyPlayer]

Another example of ABBIE not being ready for prime time, even after all of these years of Aguilar trying to sell it. Everything is "potential", "expected", and bunch of maybes.

[Myth]

lets do a simple " Fact " check....

https://www.abstractsonline.com/pp8/#!/20272/presentation/1254

Wait until people realize SHMN showing off at these conferences in the spring is just them buying a ticket and attending.

They don't have an exhibit or are they speaking about ABBIE during the conference.

[Myth]

https://www.abstractsonline.com/pp8/#!/20272/presentation/1254

AACR Annual Meeting 2024 Itinerary Planner
Session PO.ET01.03 - Cancer Biology and Metastasis
3175 / 23 - Dear ABBIE, edit that colon cancer

April 8, 2024, 1:30 PM - 5:00 PM Section 22
Presenter/Authors
D. C. Aguilar, A. Gallegos;
SOHM, INC., Chino Hills, CA
Disclosures
D. C. Aguilar,
SOHM Inc Employment.
A. Gallegos,
SOHM Inc Employment.
Abstract
Genome editing has exciting potential for gene therapy of cancers. Colorectal cancer is the third most occurring cancer in both men and women. The current treatments for colon cancers include surgery, radiofrequency ablation, chemotherapies and immunotherapies. These either involve removal of intestinal tissue that can alter the quality of life of the patient, or require doses of drugs that generally result in various side effects. ABBIE (A Binding Based Integrase Enzyme) genome editing can insert operational gene sequences into a chosen site in the genomic DNA of cells via its targetability and integrase activity. The ABBIE system offers ease of use, faster time to a readout and decreased time per genome editing experiment. SW480 and Caco-2 colon adenocarcinoma cells were used with the ABBIE system to integrate a GFP donor sequence into a safe harbor locus of the genome. Integration is to be confirmed with fluorescence microscopy and DNA sequencing. The colon cancer cell line will then be edited with the ABBIE genome editing system to include a gene cassette that overexpresses caspase genes into the genomic DNA of these cells. ABBIE-Edited colon cancer cell lines are expected to exhibit increased apoptosis as compared to non-edited controls or controls edited with DNA that do not have the caspase genes. This strategy will help lead to novel and more targetable treatments for colon cancer.

[Myth]

Tweet


SOHM, Inc.
@sohminc
Witness a paradigm shift at #AARC2024 as we unveil our groundbreaking gene-editing platform! It will revolutionize colon cancer treatment.

More: http://bit.ly/sohmaacr24

[Myth]

Maybe they mean send them an e-mail.....

why would any co want to put up with asshole bashers on X ?

do you think a newbie can figure that much out ?

Doesn't give a newbie an impression of credibility.

It's hardly a " Big Problem "....

[drugmanrx]

Here a big problem with SOHM.

They say this on twitter

"If you need further refinement or have any additional requests, feel free to ask!"

But when you try to ask on twitter, you get

"Who can reply?
Accounts @sohminc mentioned can reply"

Doesn't give a newbie an impression of credibility.

[Myth]

I believe that day is coming JD, we're one step closer....

we might even pull in some Japanese investors here too eventually, who knows..

[SLC-JD]

Agreed. For most companies in a similar position, simply announcing the licensing discussions would be enough to spark some activity. The market's non-reaction is further evidence that SHMN needs to demonstrate concrete results that impact the bottom line.

[trader guy]

Stirring up some business at DCAT along with an ABBIE licencing deal could really get things going here.